- Home
- Equipment
- united kingdom
- respiratory infections
Show results for
Refine by
Respiratory Infections Equipment Supplied In United Kingdom
8 equipment items found
Manufactured by:SpeeDx based inSydney, AUSTRALIA
Detect COVID-19 causative coronavirus, SARS-CoV-2; Multiplex RT-qPCR test with dual targets (RdRp/ORF1ab) and RNA-based internal control in a single-well. Scalable solution supporting surge ...
Manufactured by:AstraZeneca based inCambridge, UNITED KINGDOM
IVX-A12 is being designed to target both RSV and hMPV in a single vaccine candidate. hMPV is being increasingly recognized as a major contributor to acute respiratory infection and pneumonia with rates of pneumonia (Clinics in Chest Medicine 2017) and hospitalization (JID 2012) similar to that of RSV and influenza. RSV, hMPV, and influenza seasons show high ...
Manufactured by:Neogen Corporation based inLansing, MICHIGAN (USA)
UNIPRIM is an FDA approved, fast-acting, powerful antibiotic for horses used to treat a wide spectrum of bacterial infections. A combination of 67 mg trimethoprim and 333 mg sulfadiazine per gram provides effective antibacterial activity. UNIPRIM was designed specifically for horses and is cost-effective when compared to other ...
Manufactured by:The Native Antigen Company based inOxford, UNITED KINGDOM
This product is a concentrated source of highly-purified human Adenovirus type 11 particles (wild-type) from a lysate of optimally-infected 293 cells. Following double CsCl gradient purification with DNase treatment and dialysis, our Ad11 preparation is of very high quality, with minimal lot-to-lot variation. This product has been referenced by Thoma, 2013 and Dyer, ...
Manufactured by:Global Access Diagnostics (GADx) based inThurleigh (Bedfordshire), UNITED KINGDOM
Chronic respiratory diseases affect nearly 550 million people worldwide. Although these conditions are incurable, treatment is available to manage symptoms. Rapid diagnostic tests are crucial in the early detection of an exacerbation, thereby limiting the potential of unfavourable health consequences and improving the patient’s quality of ...
Manufactured by:Destiny Pharma plc based inBrighton, UNITED KINGDOM
Destiny Pharma is working in collaboration with SporeGen Limited, a UK biotechnology company working exclusively on Bacillus and its applications, to co-develop SporeGen’s SPOR-COV™ product as a novel, preventive treatment for COVID-19. SPOR-COV™ prophylactic approach targets the innate immune system with potential to develop COVID-19 protection within a few days of treatment. ...
Manufactured by:Alnylam Pharmaceuticals, Inc. based inCambridge, MASSACHUSETTS (USA)
ONPATTRO is a prescription medicine for adults that treats the polyneuropathy caused by an illness called hereditary ATTR (hATTR) ...
Manufactured by:Owlstone Medical Ltd. based inCambridge, UNITED KINGDOM
Collecting respiratory droplets exhaled as breath aerosols enables the collection of non-volatile biomarkers for analysis using a range of established analytical ...